Pharma brands can boost margins by addressing hidden inefficiencies via gross-to-net management, SKU rationalisation, price-pack strategies, trade spend optimisation, salesforce productivity, inventory control, and targeted rural distribution in India.

Optimize mature pharma portfolios by managing gross-to-net margins, improving trade spend efficiency, reducing working capital, rationalizing SKUs, tailoring price-pack architecture, optimizing inventory, and expanding into rural markets with strong channel strategies and secondary sales visibility.